Irena Loryan

About Irena Loryan

Irena Loryan, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Uppsala Universitet, specializes in the field of neuroscience, pharmacy, pharmacokinetics, brain drug delivery.

His recent articles reflect a diverse array of research interests and contributions to the field:

The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier

Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy

Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution

Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel-NeuroDeRisk project

Active uptake of oxycodone at both the blood-cerebrospinal fluid barrier and the blood-brain barrier without sex differences: a rat microdialysis study

SLC7A1 is a novel candidate for the transport of therapeutics across the blood-brain barrier

Differential Blood–Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro

P16-11 In search of sensitive safety biomarkers of peripheral neurotoxicity in the rat: a collaborative effort across industry and academia (IMI NeuroDeRisk project)

Irena Loryan Information

University

Position

Researcher Translational PKPD Group

Citations(all)

666

Citations(since 2020)

425

Cited By

373

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

16

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Irena Loryan Skills & Research Interests

neuroscience

pharmacy

pharmacokinetics

brain drug delivery

Top articles of Irena Loryan

The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier

European Journal of Cell Biology

2024/6/1

Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy

Fluids and Barriers of the CNS

2024/2/8

Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution

International Journal of Molecular Sciences

2023/11/29

Thierry Langer
Thierry Langer

H-Index: 33

Irena Loryan
Irena Loryan

H-Index: 11

Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel-NeuroDeRisk project

Biomedicine & Pharmacotherapy

2023/11/1

Active uptake of oxycodone at both the blood-cerebrospinal fluid barrier and the blood-brain barrier without sex differences: a rat microdialysis study

Pharmaceutical research

2023/11

SLC7A1 is a novel candidate for the transport of therapeutics across the blood-brain barrier

2023/6/18

Differential Blood–Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro

Pharmaceutics

2023/5/16

P16-11 In search of sensitive safety biomarkers of peripheral neurotoxicity in the rat: a collaborative effort across industry and academia (IMI NeuroDeRisk project)

Toxicology Letters

2022/9/1

P16-14 Neurofilament light chain in plasma as an early and predictive biomarker of peripheral neurotoxicity: in vivo mouse studies with oxaliplatin and paclitaxel–NeuroDeRisk …

Toxicology Letters

2022/9/1

Professor Margareta Hammarlund-Udenaes-A Humble Scientist Shaping Modern Neuropharmacokinetics

Pharmaceutical research

2022/7

Irena Loryan
Irena Loryan

H-Index: 11

Per Artursson
Per Artursson

H-Index: 55

Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development

Pharmaceutical research

2022/7

Drug Discovery Methods for Studying Brain Drug Delivery and Distribution

2022/5/25

Brain barriers virtual: an interim solution or future opportunity?

Fluids and Barriers of the CNS

2022/3/1

Unbound Brain‑to‑Plasma Partition Coefficient, K

2022

Cellular uptake and intra-brain distribution of cyclic cell penetrating peptides: why tissue and cell type matters

2021

Dual behavior of cyclic peptides at the blood-brain barrier vs brain cellular uptake: Importance for CNS drug development

2021

Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier

Molecular Psychiatry

2021/12

In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging

2021/1/3

Brain distribution of drugs: Pharmacokinetic considerations

2020/12/1

Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis

Archives of Toxicology

2020/8

See List of Professors in Irena Loryan University(Uppsala Universitet)